Last reviewed · How we verify
Edema in cirrhotic patients unresponsive to fluid and sodium restriction
Approved treatments
- Aldactone · Pfizer Inc.
Aldosterone antagonist causing increased sodium and water excretion while retaining potassium.
Clinical guidelines
- FDA label — 2L
Spironolactone is indicated for the management of edema in adult patients who are cirrhotic when edema is not responsive to fluid and sodium restrictions. - FDA label — 2L
Spironolactone is indicated for the management of edema in the setting of nephrotic syndrome when treatment of the underlying disease, restriction of fluid and sodium intake, and the use of other diuretics produce an inadequate response.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Edema in cirrhotic patients unresponsive to fluid and sodium restriction patent landscape — cliff calendar, originator estates, attackable patents
- Edema in cirrhotic patients unresponsive to fluid and sodium restriction treatment landscape brief
- Edema in cirrhotic patients unresponsive to fluid and sodium restriction treatment updates RSS
Frequently asked questions about Edema in cirrhotic patients unresponsive to fluid and sodium restriction
What drugs treat Edema in cirrhotic patients unresponsive to fluid and sodium restriction?
Tracked treatments include Aldactone.
What is the treatment for Edema in cirrhotic patients unresponsive to fluid and sodium restriction?
Standard treatment for Edema in cirrhotic patients unresponsive to fluid and sodium restriction includes Aldactone. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Edema in cirrhotic patients unresponsive to fluid and sodium restriction?
FDA label publishes guidelines for Edema in cirrhotic patients unresponsive to fluid and sodium restriction. 2 guideline references tracked.
Related
- Treatment landscape: Edema in cirrhotic patients unresponsive to fluid and sodium restriction patent cliff · Edema in cirrhotic patients unresponsive to fluid and sodium restriction CI report
- Treatment: Aldactone · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing